Jefferies Says No Changes to Ests on Amgen (AMGN) Amid Parsabiv CRL; Affirms at 'Buy'

Go back to Jefferies Says No Changes to Ests on Amgen (AMGN) Amid Parsabiv CRL; Affirms at 'Buy'
Amgen Inc (NASDAQ: AMGN) Delayed: 393.16 --0 (-0%)
Previous Close $393.16    52 Week High $176.85 
Open $393.16    52 Week Low $133.64 
Day High $393.16    P/E 59.21 
Day Low $393.16    EPS $6.64 
Volume 2,441